Foralumab to advance into Phase 2 human clinical trials using the world’s only fully human intranasal anti-CD3 monoclonal antibody
Trial to be overseen by Brigham and Women’s Hospital, a founding member of Mass General Brigham Healthcare System
Tuesday, August 15, 2023
Iziana: IND Clearance of Intranasal Foralumab for Treatment of Alzheimer’s
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.